[1] JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (UNAIDS). 2024 Global AIDS Update[EB/OL]. Geneva: UNAIDS, 2024,[2024-01-20]. http://www.unaids.org/en. [2] WORLD HEALTH ORGANIZATION. HIV statistics, globally and by WHO region, 2023[EB/OL]. Geneva: World Health Organization, 2024.[2024-01-20]. https://www.who.int. [3] 中国疾病预防控制中心性病艾滋病预防控制中心. 2024年12月全国艾滋病性病疫情[J]. 中国艾滋病性病, 2025, 31(3):225. [4] MANOSUTHI W, CHAROENPONG L, SANTIWARANGKANA C, et al.A retrospective study of survival and risk factors for mortality among people living with HIV who received antiretroviral treatment in a resource-limited setting[J]. AIDS Res Ther, 2021, 18(1):71. [5] PU JF, WU J.Survival analysis of PLWHA undergoing combined antiretroviral therapy: exploring long-term prognosis and influencing factors[J]. Front Public Health, 2024, 12: 1327264. [6] GOVENDER RD, HASHIM MJ, KHAN MA, et al.Global Epidemiology of HIV/AIDS: A Resurgence in North America and Europe[J]. J Epidemiol Glob Health, 2021, 11(3): 296-301. [7] YOU Q, QIAO J, PENG Q, et al.HIV-1 Infection Promotes Cholesterol Aggregation by Inducing miR-33b-5p to Suppress ABCA1 Expression[J]. AIDS Res Hum Retroviruses, 2023, 39(9): 459-467. [8] GODFREY C, BREMER A, ALBA D, et al.Obesity and Fat Metabolism in Human Immunodeficiency Virus-Infected Individuals: Immunopathogenic Mechanisms and Clinical Implications[J]. J Infect Dis, 2019, 220(3): 420-431. [9] STAMBULLIAN M, FELIU MS, CASSETTI LI, et al.Nutritional Status and Lipid Profile in HIV-Infected Adults[J]. Endocr Metab Immune Disord Drug Targets, 2015, 15(4): 302-307. [10] VERDON R, DAUDON M, ALBESSARD F, et al.Indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus[J]. Clin Infect Dis, 2002, 35(5): e57-e59. [11] 刘昌, 孟凡迪, 王瑞涛. 胆石病基础研究现状与展望[J]. 中国实用外科杂志, 2021, 41(1): 48-51. [12] DÖRING AK, TITEL T, WILLY C, et al. HIV: Erhöhtes Risiko für postoperative Infektionen[J]. 2021, 163(Suppl 2): 36-41. [13] 中国性病艾滋病防治协会学术委员会外科学组, 中华医学会热带病与寄生虫学分会外科学组, 国家传染病医学中心(北京). 中国人类免疫缺陷病毒感染者围手术期抗病毒治疗专家共识(第二版)[J/CD]. 中华实验和临床感染病杂志(电子版), 2021, 15(5): 289-294. [14] 赵勇, 魏国, 何永. 普外手术对HIV感染患者临床及免疫学影响[J]. 西部医学, 2018, 30(01): 59-63. [15] ASO K, ITO K, TAKEMURA N, et al.Outcomes following cholecystectomy in human immunodeficiency virus-positive patients treated with antiretroviral therapy: A retrospective cohort study[J]. Glob Health Med, 2022, 4(6):309-314. [16] LIU A, LIU C, DENG X, et al.The association between serum CD4 T lymphocyte counts and surgical outcomes in HIV/AIDS patients in Guangxi, China: a retrospective cohort study[J]. Peer J, 2021, 9:e12023. [17] 中华医学会感染病学分会艾滋病学组,中国疾病预防控制中心. 中国艾滋病诊疗指南(2024版)[J/CD].新发传染病电子杂志,2024, 9(4):68-94. [18] 世界华人医学真菌专业委员会. 侵袭性肺真菌病诊断路径专家共识(2024版)[J]. 中华检验医学杂志, 2025, 48(48):459-568. [19] 中华医学会呼吸病学分会感染学组, 中华结核和呼吸杂志编辑委员会. 肺真菌病诊断和治疗专家共识[J].中华结核和呼吸杂志, 2007, 30(11):821-834. [20] 王宁, 李刚, 龚胜, 等. 非小细胞肺癌合并HIV感染/AIDS手术患者病理和临床特征及术后并发症影响因素分析[J/CD]. 新发传染病电子杂志, 2024, 9(2):29-33. [21] 王正力, 吴德利, 吴晓明. HIV合并腹部外科手术相关感染危险因素研究[J]. 现代医药卫生, 2023, 39(14): 2412-2416. [22] CRIBBS SK, CROTHERS K, MORRIS A.Pathogenesis of HIV-Related Lung Disease: Immunity, Infection, and Inflammation[J]. Physiol Rev, 2020, 100(2):603-632. [23] COSTINIUK CT, SAMARANI S, WANG L, et al.Rôle potentiel des macrophages alvéolaires dans la persistance du VIH et les maladies pulmonaires[J]. Virologie (Montrouge), 2024, 28(4):255-276. [24] LIU S, LIU ZC, ZHANG MY, et al.ICAM-1 mediated cell-cell adhesion exerts dual roles on human B cell differentiation and IgG production[J]. iScience, 2023, 26(12):108505. [25] SHIBATA S, KIKUCHI T.Pneumocystis pneumonia in HIV-1-infected patients[J]. Respir Investig, 2019, 57(3):213-219. [26] CILLÓNIZ C, DOMINEDÒ C, ÁLVAREZ-MARTÍNEZ MJ, et al. Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients[J]. Expert Rev Anti Infect Ther, 2019, 17(10):787-801. [27] EPLING BP, LISCO A, MANION M, et al.Impact of Anti-CD4 Autoantibodies on Immune Reconstitution in People With Advanced HIV[J]. Clin Infect Dis, 2025, 80(6):1340-1348. |